CervoMed Inc (CRVO)
24.18
-0.22
(-0.88%)
USD |
NASDAQ |
May 09, 16:00
24.18
0.00 (0.00%)
After-Hours: 17:40
CervoMed Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2012 | -0.5681 |
| June 30, 2012 | -0.5633 |
| March 31, 2012 | -1.084 |
| December 31, 2011 | -0.0346 |
| September 30, 2011 | 0.2539 |
| June 30, 2011 | 0.153 |
| March 31, 2011 | -3.836 |
| December 31, 2010 | 98.32 |
| September 30, 2010 | 1.346 |
| June 30, 2010 | 1.270 |
| March 31, 2010 | 1.560 |
| December 31, 2009 | 0.3045 |
| Date | Value |
|---|---|
| September 30, 2009 | 50.63 |
| June 30, 2009 | 4.609 |
| March 31, 2009 | 8.280 |
| December 31, 2008 | 7.324 |
| September 30, 2008 | -2.535 |
| June 30, 2008 | -3.172 |
| March 31, 2008 | -5.401 |
| December 31, 2007 | -2.745 |
| September 30, 2007 | -0.3682 |
| June 30, 2007 | -0.3927 |
| March 31, 2007 | -0.506 |
| December 31, 2006 | -0.5246 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| GlucoTrack Inc | -- |
| Regen BioPharma Inc | -0.134 |
| AIM ImmunoTech Inc | 0.00 |
| Protalix BioTherapeutics Inc | 0.6033 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.972M |
| Total Liabilities (Quarterly) | 2.596M |
| Shareholders Equity (Quarterly) | 7.377M |